12 Health Care Stocks Moving In Friday's Pre-Market Session

 

  • Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
  • Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
  • Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Share Price: $0.80
Min. Investment: $1,000
Valuation: $3.5B

Gainers

  • Genfit GNFT stock moved upwards by 38.55% to $4.6 during Friday's pre-market session. The market value of their outstanding shares is at $210.4 million.
  • Cerner CERN stock rose 16.24% to $92.4. The market value of their outstanding shares is at $27.1 billion.
  • Kiora Pharmaceuticals KPRX shares moved upwards by 14.94% to $1.0. The company's market cap stands at $12.6 million.
  • Vicarious Surgical RBOT stock rose 11.52% to $12.0. The market value of their outstanding shares is at $1.4 billion.
  • Eloxx Pharmaceuticals ELOX stock rose 9.39% to $0.72. The market value of their outstanding shares is at $62.1 million.
  • BioLine Rx BLRX stock increased by 8.71% to $2.37. The market value of their outstanding shares is at $112.6 million.
  •  

Losers

  • Abeona Therapeutics ABEO shares decreased by 22.19% to $0.38 during Friday's pre-market session. The company's market cap stands at $38.7 million.
  • Kintara Therapeutics KTRA stock fell 11.3% to $0.55. The company's market cap stands at $26.6 million.
  • Motus GI Hldgs MOTS shares declined by 9.4% to $0.48. The company's market cap stands at $23.1 million.
  • Star Equity Hldgs STRR shares declined by 7.84% to $2.35. The market value of their outstanding shares is at $13.5 million.
  • Addex Therapeutics ADXN shares declined by 7.11% to $6.67. The company's market cap stands at $37.9 million.
  • Sonoma Pharmaceuticals SNOA stock decreased by 6.86% to $4.35. The market value of their outstanding shares is at $13.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Comments
Loading...